Research Article

YQFM Alleviates Side Effects Caused by Dasatinib through the ROCK/MLC Pathway in Mice

Figure 4

Effect of YQFM on the contents of ALT and AST in mice with Dasatinib. YQFM (0.336, 0.672, 1.342 g/kg, i.p.) was injected intraperitoneally 1 h before being administered with dasatinib (70 mg/kg for 3 d, i.p.). (a, b) Content of ALT and AST were analysed by using kits. Data are expressed as the mean ± SD, n = 6. vs. control mice; vs. control group; vs. model mice; vs. model group.
(a)
(b)